Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. (Q33776074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

Edda Sciutto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

Roger Carrillo-Mezo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Agnès Fleury

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Teresa Corona

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

123-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

Parasite contamination of soil in households of a Mexican rural community endemic for neurocysticercosis

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Human cysticercosis and Indian scenario: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

The disease burden of Taenia solium cysticercosis in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Neurocysticercosis, a persisting health problem in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

An epidemiological study of familial neurocysticercosis in an endemic Mexican community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Clinical aspects of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Neurocysticercosis in the United States: review of an important emerging infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Neurocysticercosis in children: clinical characteristics and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Genetic diversity of Taenia solium cysticerci from naturally infected pigs of central Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Genetic polymorphism in Taenia solium cysticerci recovered from experimental infections in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cysticercosis of the fourth ventricle causing sudden death: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Deaths associated with cysticercosis. Report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cerebral cysticercosis manifesting as hydrocephalus--case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cysticercal chronic basal arachnoiditis with infarcts, mimicking tuberculous pathology in endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Chronic hydrocephalus in rats and humans: white matter loss and behavior changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Brain metabolism in adult chronic hydrocephalus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Impairment of spatial memory in kaolin-induced hydrocephalic rats is associated with changes in the hippocampal cholinergic and noradrenergic contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Is dementia reversible in patients with neurocysticercosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Visual loss in cysticercosis: analysis of 23 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

The pretectal syndrome: 206 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Parkinsonism associated with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Pathophysiology of parkinsonism due to hydrocephalus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

In neurocysticercosis, CSF cytokines correlate with cerebral blood flow velocities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cerebral cysticercosis and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cysticercosis and cerebrovascular disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Occlusion of the middle cerebral artery due to cysticercotic angiitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Uncommon presentations of neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Inflammatory aneurysm due to neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cysticercosis of cerebellopontine cistern: differential diagnosis using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Cerebellopontine angle cysticercus and concurrent vascular compression in a case of trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

The immune response in Taenia solium cysticercosis: protection and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Neurocysticercosis: relationship between the developmental stage of metacestode present and the titre of specific IgG in the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Surgical management of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Endoscopic removal of cisternal neurocysticercal cysts. Technical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Medical treatment for neurocysticercosis: drugs, indications and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Tremor as the result of shunt obstruction: four patients with cysticercosis and secondary parkinsonism: report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

Systemic corticosteroid therapy--side effects and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.150

21 January 2018

Identifiers

DOI

10.1586/ERI.10.150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21171883%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference